SCHEMBL12118024

SCHEMBL12118024

O=C(Nc1cc(CCc2ccccc2)ccc1C(=O)O)c1cc(N2CCCCC2)ccc1O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.46
SMN1; SMN2 Q16637 5/20 0.46
NPC1 O15118 4/20 0.46
LRRK2 Q5S007 2/20 0.44
RAB9A P51151 4/20 0.42
ALOX15 P16050 1/20 0.42
IP6K1 Q92551 1/20 0.42
SERPINE1 P05121 2/20 0.41
ALDH1A1 P00352 3/20 0.41
KDM4E B2RXH2 2/20 0.41
MEN1 O00255 1/20 0.41
USP2 O75604 1/20 0.41
POLB P06746 1/20 0.41
HPGD P15428 1/20 0.41
BLM P54132 1/20 0.41
KMT2A Q03164 1/20 0.41
NR4A1 P22736 1/20 0.41
ASAH1 Q13510 1/20 0.40
HTR6 P50406 1/20 0.40
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12118023 0.87 HTR6 (0.43) MAPTSMN1; SMN2NPC1LRRK2RAB9A
SCHEMBL1315669 0.84 ACLY (0.49) IP6K1SERPINE1
Hydrochloric Acid SCHEMBL1316255 0.83 ACLY (0.48) IP6K1SERPINE1
Hydrochloric Acid SCHEMBL1316485 0.83 ACLY (0.48) IP6K1SERPINE1
SCHEMBL12121560 0.82 LRRK2 (0.50) MAPTSMN1; SMN2NPC1LRRK2RAB9A
SCHEMBL27847051 0.82 HDAC1 (0.48) IP6K1SERPINE1
SCHEMBL27989371 0.82 HDAC1 (0.46) LRRK2IP6K1SERPINE1
SCHEMBL1316626 0.82 SIRT6 (0.45) IP6K1SERPINE1
Hydrochloric Acid SCHEMBL1316818 0.80 ACLY (0.49) SERPINE1
SCHEMBL2270880 0.80 ALOX15 (0.60) MAPTNPC1RAB9AALOX15ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8492582-B2 N-acyl anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2013-07-23 US disclosed
US-8492582-B2 N-acyl anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2013-07-23 US disclosed
US-20110275797-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2011-11-10 US disclosed
US-20110275797-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2011-11-10 US disclosed
WO-2010087430-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF 富山化学工業株式会社 (JP) 2010-08-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275797-A1 N-ACYL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF COL14A1, COL2A1, COL1A1 MAPT 4045/4885SMN1; SMN2 1917/4885NPC1 4343/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.